STOCKHOLDERS’ EQUITY - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
1 Months Ended | 6 Months Ended | |
|---|---|---|---|
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Subsidiary, Sale of Stock [Line Items] | |||
| Number of shares issued (in shares) | 32.0 | 25.9 | |
| Net Proceeds | $ 701.9 | $ 532.8 | |
| Authorized amount of stock repurchase program | 1,000.0 | ||
| Stock available for repurchase under the stock repurchase program | 1,000.0 | ||
| 2024 Convertible Notes | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Conversion price (in usd per share) | $ 20.12 | ||
| Net Proceeds | $ 407.0 | ||
| “At the market” offerings | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Maximum issuance of common stock | 1,500.0 | ||
| Stock available for issuance | $ 791.0 | ||
| Number of shares issued (in shares) | 32.0 | 25.9 | |
| Net Proceeds | $ 701.9 | $ 532.8 | |
| Over-allotment option one | 2024 Convertible Notes | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Number of shares issued (in shares) | 20.0 | ||